SEI Investments’s Adamas Pharmaceuticals ADMS Stock Holding History

SEI Investments’s Portfolio ADMS Stock Details ADMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-4,753	Closed	-$123K	–	3641
2018 Q2	$123K	Sell	4,753 -2,874	-38%	-$79.6K	﹤0.01%	2214
2018 Q1	$182K	Buy	7,627 +2,536	+50%	+$80K	﹤0.01%	1927
2017 Q4	$173K	Sell	5,091 -3,669	-42%	-$102K	﹤0.01%	1975
2017 Q3	$185K	Buy	8,760 +8,033	+1,105%	+$147K	﹤0.01%	1906
2017 Q2	$13K	Buy	727 +373	+105%	+$6.17K	﹤0.01%	2538
2017 Q1	$6K	Buy	+354	New	+$6.03K	﹤0.01%	2561
2015 Q3	–	Sell	-72	Closed	-$2K	–	2620
2015 Q2	$2K	Buy	72 +31	+76%	+$603	﹤0.01%	2121
2015 Q1	$0	Buy	+41	New	+$703	﹤0.01%	2396

Other funds holding ADMS

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BWCA

Brenner West Capital Advisors New York $804M AUM 16.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

SEI Investments's ADMS Position: Q3 2018 in Review

SEI Investments sold out of Adamas Pharmaceuticals (ADMS) in Q3 2018, closing a stake of 4,753 shares — an estimated $123K sold.

SEI Investments first reported a position in ADMS in Q1 2015 and held it in 8 quarters. The position peaked at $185K in Q3 2017. 125 funds tracked by Wall St. Rank hold ADMS as of Q3 2018.

SEI Investments reported no remaining Adamas Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
SEI Investments sold 4,753 Adamas Pharmaceuticals shares in Q3 2018, an estimated $123K.
SEI Investments first reported a position in Adamas Pharmaceuticals in Q1 2015 and held it in 8 quarters.
SEI Investments's Adamas Pharmaceuticals position peaked at $185K in Q3 2017.
125 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q3 2018.

Based on SEI Investments's 13F filing for Q3 2018, filed 8 Nov 2018.